Cumulative Life Course Impairment in Atopic Dermatitis: A Comprehensive Review
Medical Sciences · 20.08.2026 · 14 (4) · 499
DOI: 10.3390/medsci14040499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 20.08.2026. Verfasst von Claudio Brescia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a relapsing course and a substantial multidimensional burden. Conventional clinical and patient-reported outcome measures mainly provide cross-sectional evaluations and may not fully capture the long-term impact of the disease. The concept of cumulative life course impairment (CLCI) has been proposed to describe the progressive and lifelong consequences of chronic dermatologic conditions.
Methods
This narrative review is based on a non-systematic literature search conducted in PubMed/MEDLINE and Embase up to July 2026. Relevant studies addressing quality of life, mental health, comorbidities, and economic burden in AD were identified and narratively synthesized, with particular focus on evidence supporting the CLCI framework.
Results
AD exerts a cumulative burden across multiple domains. Pruritus and sleep disturbance emerge as key drivers, contributing to a self-reinforcing cycle involving psychological distress and impaired daily functioning. Increased rates of anxiety and depression, along with social stigmatization, negatively affect interpersonal relationships, educational attainment, and work productivity. Comorbidities and the chronic relapsing nature of AD further amplify long-term impairment. Economic burden, including both direct and indirect costs, acts as both a consequence and a driver of cumulative disadvantage. Recurrent disease flares play a central role in sustaining and amplifying this trajectory over time.
Conclusions
AD should be considered a life-course disease in which interacting biological, psychological, and social factors shape long-term outcomes. A CLCI-oriented approach may improve patient stratification and support earlier, multidisciplinary, and proactive management strategies aimed at reducing long-term burden and improving overall outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
ORCID-Profile: Claudio Brescia, Luca Potestio, Maddalena Napolitano
Zitieren
APA
Brescia, C., Palagiano, C., Turco, M., Potestio, L., di Vico, F., & Napolitano, M. (2026). Cumulative Life Course Impairment in Atopic Dermatitis: A Comprehensive Review. Medical Sciences, 14(4), 499. https://doi.org/10.3390/medsci14040499
Vancouver
Brescia C, Palagiano C, Turco M, Potestio L, di Vico F, Napolitano M. Cumulative Life Course Impairment in Atopic Dermatitis: A Comprehensive Review. Medical Sciences. 2026;14(4):499. doi:10.3390/medsci14040499
BibTeX
@article{Brescia2026,
author = {Brescia, Claudio and Palagiano, Chiara and Turco, Martina and Potestio, Luca and di Vico, Francesca and Napolitano, Maddalena},
title = {Cumulative Life Course Impairment in Atopic Dermatitis: A Comprehensive Review},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {4},
pages = {499},
doi = {10.3390/medsci14040499}
}
EUVIMED